Browse

Standardized Salvia miltiorrhiza Extract as a Therapeutic Candidate for the Treatment and Prevention of Non-alcoholic Steatohepatitis
표준화 단삼추출물에 의한 비알콜성 지방간염 치료 및 예방 효과에 관한 연구

Cited 0 time in Web of Science Cited 0 time in Scopus
Authors
이학성
Advisor
김영식
Major
약학대학 제약학과
Issue Date
2015-02
Publisher
서울대학교 대학원
Keywords
Salvia miltiorrhizanon-alcoholic steatohepatitis (NASH)methionine-choline deficient (MCD)hepatic stellate cell (HSC)TGF-β1TNF-αtanshinone IIA
Description
학위논문 (박사)-- 서울대학교 대학원 : 제약학과, 2015. 2. 김영식.
Abstract
Non-alcoholic fatty liver disease (NAFLD) refers to a broad spectrum of liver damage, which ranges from simple steatosis or intracellular triglyceride accumulation to inflammation (non-alcoholic steatohepatitis
NASH) fibrosis and cirrhosis. The aim of this study was to investigate the effect of standardized extract of Salvia miltiorrhiza (SME) on gene and protein expression of NASH-related factors in activated human hepatic stellate cells (HSC), and in mice with steatohepatitis induced by a methionine-choline deficient (MCD) diet. Male C57BL/6J mice were placed on an MCD or control diet for 8 weeks and SME (0, 0.1, 0.5 and 1 mg/kg body weight) was administered orally every other day for 4 or 6 weeks. HSCs from the LX-2 cell line were treated with transforming growth factor β-1 (TGF-β1) or TGF-β1 plus SME (0.1–10 μg/mL). To investigate the effect of SME on reactive oxygen species (ROS)-induced condition, LX-2 cells were treated with hydrogen peroxide (H2O2) or H2O2 plus SME (0.1–100 μg/mL). MCD administration for 12 weeks increased mRNA expression of tumor necrosis factor (TNF-α), TGF-β1, interleukin-1β (IL-1β), C-reactive protein (CRP), α-smooth muscle actin (α-SMA), type I collagen, matrix metalloproteinase-2 (MMP-2) and MMP-9. TGF-β1-induced LX-2 cells exhibited similar gene expression patterns. SME treatment significantly reduced the mRNA and protein expression of NASH-related factors in the mouse model and HSCs. Histopathological liver analysis showed improved NAFLD activity and fibrosis score in SME-treated mice. The in vivo studies showed that SME had a significant effect at low doses. These results suggest that SME might be a potential therapeutic candidate for treatment and prevention of NAFLD.
Language
English
URI
https://hdl.handle.net/10371/120030
Files in This Item:
Appears in Collections:
College of Pharmacy (약학대학)Dept. of Manufacturing Pharmacy (제약학과)Theses (Ph.D. / Sc.D._제약학과)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse